Consolidated Statements of Cash Flows (USD $) | 9 Months Ended |
In Thousands, unless otherwise specified | Jan. 31, 2015 | Jan. 31, 2014 |
Cash flows from operating activities: | | |
Net earnings | $3,006 | $2,988 |
Adjustments to reconcile net earnings to net cash provided by operating activities: | | |
Depreciation | 1,900 | 1,846 |
Bad debt provision | 34 | 109 |
Stock based compensation expense | 154 | 186 |
Provision for deferred income tax expense | -71 | -80 |
Change in assets and liabilities: | | |
(Increase) decrease in receivables | -1,623 | 3,805 |
(Increase) decrease in inventories | -492 | 696 |
Increase (decrease) in accounts payable and other accrued expenses | 4,022 | -2,127 |
Increase (decrease) in deferred revenue | 159 | -317 |
Other, net | -750 | 126 |
Net cash provided by operating activities | 6,339 | 7,232 |
Cash flows from investing activities: | | |
Capital expenditures | -2,135 | -1,614 |
(Increase) decrease in restricted cash | -2,156 | 14 |
Net cash used in investing activities | -4,291 | -1,600 |
Cash flows from financing activities: | | |
Dividends paid | -919 | -834 |
Dividends paid to noncontrolling interest in subsidiaries | -38 | -38 |
Decrease in short-term borrowings and interest rate swap | -2,114 | -2,828 |
Proceeds from long-term debt | | 5,000 |
Payments on long-term debt | -316 | -3,748 |
Payment toward purchase of noncontrolling interest in subsidiary | -888 | -1,780 |
Net proceeds from exercise of stock options (including tax benefit) | 33 | 59 |
Net cash used in financing activities | -4,242 | -4,169 |
Effect of exchange rate changes on cash | -191 | -616 |
(Decrease) increase in cash and cash equivalents | -2,385 | 847 |
Cash and cash equivalents, beginning of period | 6,248 | 5,811 |
Cash and cash equivalents, end of period | 3,863 | 6,658 |
Supplemental Disclosure of Cash Flow Information | | |
Purchase of noncontrolling interest in subsidiary - Other accrued expenses and other non-current liabilities | | $1,775 |